OpenVSafe by OpenVAERS
Search V-safe

5KX-22920-16108

2 vaccinations 4 coded responses 16 check-ins 4 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
407 / KY
Registered
2021-01-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-06
    Registered in v-safe
  2. 2021-01-06
    Dose 1 — Moderna
  3. 2021-01-06
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  5. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Headache
    Adult check-in
  6. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  7. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-01-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-14
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  11. 2021-01-22
    Survey response — day 14, dose 1
    MedDRA: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site warmth, Skin lesion, Type IV hypersensitivity reaction — Feeling: Good
    Free text: I had a delayed hypersensitivity reaction at the site of my injection including erythema, warmth, and itchiness with satellite lesions as well beginning at day 8 and then resolving day 10 after the injection. Full diameter approx 8 cm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-27
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-03
    Dose 2 — Moderna
  14. 2021-02-03
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  15. 2021-02-12
    Survey response — day 7, dose 2
    MedDRA: Unevaluable event — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: These symptoms persisted from Thursday 4-today feb 12
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-12
    Report sent to call center — day 7, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-02-17
    Survey response — day 14, dose 2
    MedDRA: Dyspnoea, Fatigue — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Non resolved sob and fatigue resulting in ekg that was abnormal. Scheduled for ECHO and Stress test
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-17
    Report sent to call center — day 14, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-03-17
    Survey response — day 42, dose 2
    MedDRA: Chest pain, Dyspnoea, Fatigue, Myocardial infarction, Thrombosis, Vasospasm — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I had MI according to EKG done after symptoms doe, CP days 5-11 post vaccine # 2. Negative stress consistent with dissolved thrombus vs Vasospasm. Residual intermittent fatigue and dyspnea still present
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-17
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  21. 2021-07-31
  22. 2021-08-04
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2022-02-03
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-06Moderna
22021-02-03Moderna

Call center

3 call center cases

3 unsuccessful

VAERS report filed, before or during a call: 3

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — day 14, dose 1

2021-01-22

Symptoms: I had a delayed hypersensitivity reaction at the site of my injection including erythema, warmth, and itchiness with satellite lesions as well beginning at day 8 and then resolving day 10 after the injection. Full diameter approx 8 cm

Release 4 — day 7, dose 2

2021-02-12

Systemic reaction (other): These symptoms persisted from Thursday 4-today feb 12

Release 4 — day 14, dose 2

2021-02-17

Symptoms: Non resolved sob and fatigue resulting in ekg that was abnormal. Scheduled for ECHO and Stress test

Release 5 — day 42, dose 2

2021-03-17

Symptoms: I had MI according to EKG done after symptoms doe, CP days 5-11 post vaccine # 2. Negative stress consistent with dissolved thrombus vs Vasospasm. Residual intermittent fatigue and dyspnea still present

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest pain ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site reaction ✓ ✓ ✓
SDInjection site warmth ✓ ✓ ✓
SDMyocardial infarction ✓ ✓ ✓
SDSkin lesion ✓ ✓ ✓
SDThrombosis ✓ ✓ ✓
SDType IV hypersensitivity reaction ✓ ✓ ✓
SDVasospasm ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release